Spyre Therapeutics, Inc. (SYRE) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 763.95M | 777.78M | 504.6M | 538.83M | 569.77M | 608.47M | 421.08M | 435.74M | 487.27M | 341.53M | 205.95M | 239.89M | 44.38M | 62.26M | 82.22M | 96.65M | 72.6M | 98.89M | 117.51M | 134.37M |
| Cash & Short-Term Investments | 741.47M | 756.53M | 486.2M | 526.58M | 564.82M | 603.09M | 414.23M | 426M | 484.64M | 339.28M | 203.6M | 235.36M | 38.48M | 55.71M | 73.68M | 88.55M | 66.72M | 93.13M | 112.43M | 128.58M |
| Cash Only | 97.19M | 85.72M | 64.9M | 81.66M | 48.49M | 89.42M | 71.58M | 45.14M | 227.55M | 188.89M | 90.59M | 235.36M | 35.24M | 34.86M | 38.99M | 37.47M | 14.64M | 15.14M | 24.66M | 34.77M |
| Short-Term Investments | 644.28M | 670.81M | 421.3M | 444.92M | 516.33M | 513.66M | 342.65M | 380.85M | 257.09M | 150.38M | 113.01M | 0 | 3.23M | 20.85M | 34.69M | 51.08M | 52.09M | 77.99M | 87.76M | 93.81M |
| Accounts Receivable | 4.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 163K | 1.65M | 330K | 375K | 669K | 479K | 1.01M | 815K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | 130.68 | 160.23 | 285.86 | 303.49 | 108.54 | 60.36 | 20.58 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 17.89M | 21.25M | 18.41M | 12.25M | 4.95M | 5.39M | 6.85M | 9.74M | 2.63M | 2.25M | 2.19M | 2.88M | 5.57M | 6.17M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 10K | 10K | 10K | 331K | 329K | 331K | 1.32M | 3.64M | 8.08M | 8.89M | 9.35M | 10.06M | 10.57M | 11.04M | 11.55M | 12.61M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.32M | 6.69M | 6.65M | 7.07M | 7.5M | 7.95M | 8.36M | 8.81M | 9.22M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | 0.15x | 0.03x | 0.02x | 0.02x | 0.08x | 0.17x | 0.42x | 0.16x | 1.45x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 321K | 0 | 0 | 0 | 0 | 0 | 0 | 1.53M | 1.8M | 0 | 0 | 1.84M | 1.85M |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 10K | 10K | 10K | 10K | 329K | 331K | 1.32M | 1.33M | 1.39M | 2.24M | 749K | 752K | 2.63M | 2.68M | 897K | 1.55M |
| Total Assets | 763.95M | 777.78M | 504.6M | 538.83M | 569.78M | 608.48M | 421.09M | 436.07M | 487.6M | 341.86M | 207.26M | 243.53M | 52.45M | 71.14M | 91.57M | 106.71M | 83.17M | 109.93M | 129.06M | 146.98M |
| Asset Turnover | - | 0.14x | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.03x | 0.01x | 0.09x |
| Asset Growth % | 34.08% | 27.82% | 19.83% | 23.57% | 16.85% | 77.99% | 103.16% | 79.06% | 829.6% | 380.52% | 126.36% | 128.22% | -36.93% | -35.28% | -29.05% | -27.4% | -49.17% | -31.98% | -17.07% | -15% |
| Total Current Liabilities | 85.16M | 58.69M | 46.27M | 83.06M | 70.68M | 54.06M | 57.54M | 22.12M | 42.82M | 31.98M | 44.87M | 232.23M | 12.64M | 14.66M | 17.68M | 15.86M | 16.3M | 20.14M | 20.43M | 20.6M |
| Accounts Payable | 5.69M | 8.9M | 7.46M | 3.71M | 3.69M | 666K | 5.17M | 3.23M | 3.11M | 896K | 1.68M | 2.85M | 2.06M | 677K | 4.18M | 1.96M | 2.98M | 3.32M | 1.86M | 2.22M |
| Days Payables Outstanding | - | 16.63 | 11.35 | - | - | - | - | - | - | - | - | - | 224.92 | 455.78 | 562.26 | 473.1 | 570.42 | 474.84 | 12.65 | 13.73 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 930K | 302K | 517K | 505K | 291K | 2.07M | 2.36M | 4.79M | 5.53M |
| Other Current Liabilities | 74.4M | 49.78M | 16.32M | 63.43M | 44.74M | 52.79M | 52.37M | 16.23M | 5.1M | 5.93M | 12.88M | 182.12M | 3.14M | 4.92M | 7.72M | 9.47M | 3.11M | 4.99M | 9.67M | 9.54M |
| Current Ratio | 8.97x | 13.25x | 10.90x | 6.49x | 8.06x | 11.26x | 7.32x | 19.70x | 11.38x | 10.68x | 4.59x | 1.03x | 3.51x | 4.25x | 4.65x | 6.09x | 4.45x | 4.91x | 5.75x | 6.52x |
| Quick Ratio | 8.97x | 13.25x | 10.90x | 6.49x | 8.06x | 11.26x | 7.32x | 19.70x | 11.38x | 10.68x | 4.59x | 1.03x | 3.51x | 4.25x | 4.65x | 6.09x | 4.45x | 4.91x | 5.75x | 6.52x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.98M | 3.86M | 3.23M | 0 | 16.49M | 36.62M | 36.16M | 39.56M | 292.51M | 125.86M | 407.8M | 218.66M | 6.16M | 6.18M | 6.33M | 6.69M | 5.21M | 5.84M | 6.55M | 7.35M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.82M | 4M | 4.16M | 4.32M | 4.47M | 4.62M | 4.75M | 4.88M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.98M | 3.86M | 3.23M | 0 | 16.49M | 36.62M | 36.16M | 39.56M | 292.51M | 125.86M | 407.8M | 216.32M | 0 | 0 | 0 | 0 | 8K | 0 | 192K | 200K |
| Total Liabilities | 93.14M | 62.55M | 49.5M | 83.06M | 87.17M | 90.68M | 93.7M | 61.68M | 335.33M | 157.84M | 452.67M | 450.9M | 18.8M | 20.84M | 24.01M | 22.55M | 21.51M | 25.98M | 26.98M | 27.96M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.33M | 4.43M | 4.63M | 4.75M | 4.79M | 4.92M | 5.06M | 5.16M | 5.29M |
| Net Debt | -97.19M | -85.72M | -64.9M | -81.66M | -48.49M | -89.42M | -71.58M | -45.14M | -227.55M | -188.89M | -90.59M | -231.03M | -30.81M | -30.23M | -34.24M | -32.68M | -9.71M | -10.08M | -19.5M | -29.47M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | 0.13x | 0.09x | 0.07x | 0.06x | 0.08x | 0.06x | 0.05x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 670.81M | 715.24M | 455.1M | 455.77M | 482.61M | 517.8M | 327.39M | 374.38M | 152.27M | 184.02M | -245.4M | -207.37M | 33.65M | 50.3M | 67.56M | 84.16M | 61.66M | 83.94M | 102.08M | 119.02M |
| Equity Growth % | 39% | 38.13% | 39.01% | 21.74% | 216.95% | 181.39% | 233.41% | 280.54% | 352.48% | 265.8% | -463.26% | -346.41% | -45.42% | -40.07% | -33.82% | -29.29% | -50.18% | -39.97% | -25.09% | -21.83% |
| Book Value per Share | 1.94 | 2.07 | 7.53 | 7.51 | 8.01 | 11.01 | 6.43 | 8.26 | 4.17 | 8.48 | -57.15 | -54.25 | 8.93 | 19.24 | 17.93 | 25.59 | 23.36 | 42.52 | 38.79 | 45.34 |
| Total Shareholders' Equity | 670.81M | 715.24M | 455.1M | 455.77M | 482.61M | 517.8M | 327.39M | 374.38M | 152.27M | 184.02M | -245.4M | -207.37M | 33.65M | 50.3M | 67.56M | 84.16M | 61.66M | 83.94M | 102.08M | 119.02M |
| Common Stock | 15K | 15K | 13K | 13K | 13K | 13K | 12K | 12K | 10K | 10K | 7K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K |
| Retained Earnings | -1.2B | -1.13B | -1.07B | -1.05B | -1.02B | -972.43M | -916.14M | -847.11M | -808.27M | -764.41M | -701.23M | -661.13M | -444.05M | -425.62M | -406.8M | -388.57M | -366.25M | -341.81M | -321.36M | -301.06M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -767K | 869K | 791K | 454K | 682K | 180K | 1.46M | -553K | -363K | 302K | -132K | 11K | -6K | -48K | -184K | -220K | -153K | -20K | 2K | 11K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |